Get Your Personalized Supplement StackSupplement Stack Quiz

Gynostemma Extract

Also known as: Jiaogulan, Southern Ginseng, Sweet Tea Vine, Gynostemma extract, Gynostemma pentaphyllum

Overview

Gynostemma pentaphyllum, commonly known as Jiaogulan, is a climbing vine native to Asia, traditionally valued in herbal medicine for its adaptogenic, antioxidant, and metabolic regulatory properties. The extract, primarily derived from its leaves, contains saponins called gypenosides, which are the main bioactive compounds. It is frequently utilized for managing dyslipidemia (abnormal lipid levels) and glucose metabolism disorders, as well as a general health tonic. Research, including multiple randomized controlled trials (RCTs) and systematic reviews, has focused on its lipid-lowering and glucose-regulating effects. While the quality of evidence varies, several meta-analyses support its efficacy, particularly in improving lipid profiles. It is considered a phytochemical extract and an adaptogen, often referred to as 'Southern Ginseng' due to its similar adaptogenic qualities to Panax ginseng.

Benefits

Gynostemma pentaphyllum offers several evidence-based benefits, primarily in metabolic health: 1. **Lipid-lowering effects:** Strong evidence from systematic reviews and meta-analyses of over 2000 participants indicates that Gynostemma pentaphyllum significantly reduces total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C), while increasing high-density lipoprotein cholesterol (HDL-C). These effects are observed compared to placebo and are comparable to some pharmaceutical lipid-lowering agents, though generally less potent than red yeast rice extracts. When combined with conventional lipid-lowering drugs, Gynostemma shows superior improvements in TG, LDL-C, and HDL-C compared to drugs alone, suggesting an additive benefit for individuals with dyslipidemia. 2. **Glucose metabolism improvement:** Preclinical animal studies demonstrate that heat-processed Gynostemma extract (HGyp) can reduce blood glucose levels, improve insulin resistance, increase liver glycogen stores, and enhance antioxidant enzyme activity. This suggests potential benefits for managing diabetes and related conditions. While human data is still emerging, the animal research provides promising insights into its role in glucose regulation. 3. **Antioxidant properties:** Its gypenosides contribute to its antioxidant capacity, helping to reduce oxidative stress, which is a key factor in the development and progression of metabolic syndrome and diabetes. This general health benefit contributes to overall cellular protection.

How it works

The therapeutic effects of Gynostemma pentaphyllum are primarily attributed to its gypenosides, saponins structurally similar to ginsenosides. These compounds exert their effects through multiple mechanisms. In lipid metabolism, gypenosides influence pathways involved in cholesterol synthesis and clearance, leading to reduced levels of 'bad' cholesterol (LDL-C) and triglycerides, and increased 'good' cholesterol (HDL-C). For glucose regulation, gypenosides modulate the AGE-RAGE signaling pathway, which is implicated in inflammation and tissue damage from hyperglycemia. They also upregulate glucose transporter GLUT4, enhancing glucose uptake into cells and improving insulin sensitivity. Additionally, gypenosides possess antioxidant properties, reducing oxidative stress. While specific bioavailability data is limited, heat processing may enhance the availability of active constituents, particularly for glucose metabolic benefits.

Side effects

Gynostemma pentaphyllum is generally well-tolerated, with clinical trials reporting no common (>5%) or serious adverse effects over periods of up to 12 weeks or longer. However, specific safety data for pregnant or breastfeeding women, children, and individuals with severe underlying health conditions are limited, and these populations should consult a healthcare provider before use. While no significant drug interactions have been formally documented, caution is advised when combining Gynostemma with lipid-lowering medications (e.g., statins) or antidiabetic drugs (e.g., metformin, insulin) due to the potential for additive effects. This could theoretically lead to excessive reductions in blood lipids or glucose, necessitating careful monitoring and potential dose adjustments of conventional medications. There are no established contraindications, but individuals with known allergies to plants in the Cucurbitaceae family (gourd family) should exercise caution. Overall, its safety profile appears favorable for short-to-medium term use in healthy adults, but long-term safety data beyond 12 weeks is still emerging.

Dosage

Clinical trials on Gynostemma pentaphyllum have utilized varied dosages, with typical effective ranges for extract approximately from 300 mg to 900 mg daily. To observe significant lipid-lowering effects, a duration of at least 8 weeks of consistent supplementation is generally necessary. For glucose metabolism benefits, heat-processed extracts may offer enhanced efficacy. The daily dose in clinical studies has not exceeded 1 gram per day, and there is no established maximum safe dose. It is important to note that the specific form of the extract (e.g., standardized gypenoside content) can influence efficacy, though this is not always specified in research. As with any supplement, it is advisable to start with a lower dose and gradually increase, while monitoring for effects and consulting with a healthcare professional, especially if combining with other medications.

FAQs

Is Gynostemma safe for long-term use?

Evidence supports its safety for at least 8–12 weeks based on clinical trials. Longer-term safety data beyond this period is currently limited, so extended use should be discussed with a healthcare professional.

Can Gynostemma replace statins or other lipid-lowering drugs?

Gynostemma's lipid-lowering effects are comparable to some agents but generally less potent than statins or red yeast rice. It is best considered as an adjunct therapy rather than a replacement for prescribed medications, especially for significant dyslipidemia.

When can I expect to see benefits from Gynostemma?

Improvements in lipid profiles are typically observed after at least 8 weeks of consistent daily supplementation. Benefits related to glucose metabolism may also require a similar duration.

Does the processing of Gynostemma affect its efficacy?

Yes, preclinical research suggests that heat-processed Gynostemma extract may have enhanced efficacy, particularly for improving glucose metabolism and related parameters, compared to unprocessed forms.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC9459123/ – This systematic review and meta-analysis of 27 RCTs (2311 participants) found that Gynostemma pentaphyllum significantly lowered total cholesterol, triglycerides, and LDL-C, while increasing HDL-C in individuals with dyslipidemia. It was deemed safe, though less effective than red yeast rice, and showed additive benefits when combined with lipid-lowering drugs. The study noted moderate heterogeneity and low to moderate certainty evidence.
https://pubmed.ncbi.nlm.nih.gov/36091752/ – This is likely the same meta-analysis as the first source, confirming the lipid-lowering efficacy and safety of Gynostemma pentaphyllum based on 27 RCTs. It supports the clinical use of Gynostemma for hyperlipidemia, acknowledging potential publication bias and a predominant focus on Chinese populations in the included studies. The quality was assessed as moderate with robust statistical methods.
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1215150/full – This preclinical animal study investigated the effects of heat-processed Gynostemma extract (HGyp) in mice with diet-induced glucose metabolic disorders. It demonstrated that HGyp reduced blood glucose, improved lipid profiles, and modulated the AGE-RAGE signaling pathway. This research provides promising mechanistic insights into Gynostemma's potential for diabetes management, though human validation is needed.